US Patent Issued to Pfizer, Bristol-Myers Squibb on July 29 for "Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof" (American, Irish, Chinese Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,372,536, issued on July 29, was assigned to Pfizer Inc. (New York) and Bristol-Myers Squibb Co. (Princeton, N.J.).

"Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof" was invented by Robert Arch (St. Louis), Jun Zhang (Beijing), Michelle Mader (Arlington, Mass.), Tetsuya Ishino (Boston), Joel Bard (Newton, Mass.), William Finlay (Dublin), Orla Cunningham (Dublin), Ciara Reilly (Dublin), Peter Brams (Sacramento, Calif.), Brigitte Devaux (Palo Alto, Calif.), Haichun Huang (Fremont, Calif.) and Karla Henning (Milpitas, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides antibodies, o...